NEW YORK (WPIX) – The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday. Spravato is a first-of-its-kind medication to ...

The nasal spray Spravato, which is made from the drug ... Esketamine, which Spravato is derived from, is a molecule related to the anesthetic ketamine. According to the manufacturer, Spravato ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato ... However, medication involving the anesthetic, ketamine, has shown promise ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

A Washington Democrat hopes to study the impact of medical anesthesia on climate change. The goal is to address the environmental impact of the anesthetic gases used in medical, dental and ...